Research on women’s health highlights distinct physiological, hormonal, and environmental factors that influence disease risk, diagnosis, and treatment outcomes across the lifespan.

Biologically, sex chromosomes and reproductive hormones shape immune responses and metabolism. Estrogen often provides vascular and metabolic protection before menopause but can also modulate immune activity, partly explaining why women have higher rates of many autoimmune diseases. Pregnancy introduces major cardiovascular and metabolic stresses; complications such as preeclampsia and gestational diabetes are now recognized as early warning signs of future hypertension, heart disease, and type 2 diabetes.

Cardiovascular research shows that women can present different heart attack symptoms, are more likely to have microvascular and stress induced cardiomyopathies, and have historically been underdiagnosed and undertreated. Sex specific patterns also appear in arrhythmias and heart failure, with differing drug responses and side effect profiles.

In brain health, sex differences emerge in migraine prevalence, stroke risk across ages, and susceptibility to certain neurodegenerative and psychiatric conditions. Hormonal transitions at puberty, during menstrual cycles, pregnancy, and menopause affect mood, cognition, and vascular risk in complex ways.

Cancer studies reveal distinct risk patterns for breast, ovarian, cervical, and endometrial cancers, along with sex related differences in incidence and outcomes for non reproductive cancers such as lung and colorectal cancer. Genetics, hormones, and lifestyle all interact in these risks.

Across fields, a key theme is the historical underrepresentation of women in clinical research and the need for sex specific data. Current work emphasizes personalized prevention and treatment strategies that account for sex, hormones, life stage, and social determinants of health.